June 19, 2018 7 AM - 9 AM PDT
7:30-8:00 AMBreakfast and Announcements
Frustrated with the lack of innovation in women’s health, Sabrina Martucci Johnson, a successful life sciences executive, and Lisa Walters-Hoffert, a successful investment banker, came together to form a purpose-built company called Dare. After exploring a variety of corporate structures, the founders realized the only way to stay true to their idea was to form their own, independent company. With the help and support of two additional strategically aligned co-founders, Daré Bioscience came to life in 2015. Join us for a discussion of this company’s powerful journey from seed financing to NASDAQ listing via reverse merger; a journey that includes raising over 20 million, building a highly differentiated portfolio of product candidates, securing non-dilutive investments from the NIH, and assembling a world-class team.
Our panel will provide insights from three different perspectives: (i) Co-founder and CFO, (ii) Co-founder, Seed investor and Board Chair, and (iii) Legal advisor from the beginning.
Lisa Walters-Hoffert, Co-founder & Chief Financial Officer of Daré
Roger Hawley, Co-founder, Seed Investor & Chairman of the Board of Daré
Jeremy Glaser, Co-Chair Venture Capital & Emerging Companies Practice of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Contact Executive Director Judy Susser-Travis, CMP, CMM at email@example.com or 619 741 7247